Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Background
- Consensus paper, 2014
- Surgical treatment of pulmonary TB: Milestones
- Antibacterial era
- Indications for surgical treatment of the pulmonary TB and M/XDR-TB
- Emergency indications
- Urgent indications
- Elective indications
- Important conditions for elective surgery in TB
- Types of operations
- Contraindications for elective surgical treatment of pulmonary TB & M/XDR-TB
- Preoperative management: Patient-centred approach (1)
- Preoperative management: Patient-centred approach (2)
- Preoperative management: Patient-centred approach (3)
- Untreatable tuberculosis: Is surgery the answer?
- Resection of tuberculomas
- Meta-analysis of lung resection surgery for MDR-TB patients vs. non-surgery
- Surgery for patients on MDR-TB treatment
- Surgery for TB and National TB programme
- Conclusions
Topics Covered
- History of surgical treatment of pulmonary TB
- Indications for surgical treatment of TB
- Types of operations
- Preoperative management
- Surgical versus non-surgical treatment methods
- Surgery in TB and MDR/XDR
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Zaleskis, R. (2021, July 28). The role of surgery in tuberculosis management [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 8, 2024, from https://doi.org/10.69645/UANQ5410.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Richard Zaleskis has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
The role of surgery in tuberculosis management
Published on July 28, 2021
27 min
A selection of talks on Microbiology
Transcript
Please wait while the transcript is being prepared...
0:00
Dear colleagues, my name is Richard Zaleskis.
I am a medical doctor and have a PhD in surgery.
For 12 years I was Regional Advisor for TB control in
the WHO regional office for Europe and I came back to
my country Latvia in 2012 and continue
my professional activities as an international expert on TB control,
as well as a lecturer and facilitator of the WHO Collaborating Center for Research and Training in the Management of MDR-TB in Riga, Latvia.
I am also the Chairman of the Latvian Society against TB.
The topic of my lecture today is "The Role of Surgery in Tuberculosis Management".
Although significant progress has been
achieved in the treatment of drug susceptible TB cases,
we have still serious challenges to successfully treat
drug-resistant TB that have posed a substantial threat to global TB control.
With few treatment options for such base search,
we are pushed often to the pre-antibiotic era and many patients remain untreatable.
With such challenges circumstances of a need of a region to treat
MDR-TB and extensively drug-resistant TB in particular,
the role of surgery is being
reoriented as one of the main treatment options for TB and drug-resistant TB.
1:36
The effectiveness of surgery in the management of pulmonary TB and
drug-resistant TB has not yet been duly documented and evaluated.
Its role is not well established and practices vary across the WHO European region.
That's why in 2012,
the WHO regional office for Europe established
a special task force on the role of surgery in drug-resistant TB to
review the current evidence-based papers and to provide
an expert opinion on surgical treatment of pulmonary TB and multidrug-resistant TB,
as well as extensively drug-resistant TB.
I have the great pleasure and honor to coordinate this taskforce and
participants of this taskforce for surgery from
the East and from the West and from the former Soviet Union.
That's why it's not so easy at the beginning to achieve some consensus on
the different topics, of different issues on indications and contraindications for TB surgery.
But finally, we achieved a very good consensus and developed a special Consensus paper.